Articles > quality improvement
The T1D Exchange Quality Improvement Collaborative (QIC) is a T1D learning health system that includes over 10 endocrinology centers nationwide, working collaboratively on a shared goal of improving outcomes for people with T1D. The program is coordinated by the QI team at T1D Exchange in Boston.
T1D Exchange today announced the launch of a population health surveillance study of individuals with type 1 diabetes (T1D) who are suspected or confirmed to have contracted Coronavirus Disease 2019 (COVID-19). The results of the study will be used to better understand the etiology and potential outcomes in COVID-19 patients and inform future clinical quality improvement activities to better respond to the global pandemic.
Speaking at the T1D Exchange annual meeting, Glooko Chief Medical Officer Dr. Mark Clements shares how un-siloed health data has the potential to reshape the care provided to people with type 1 diabetes.
In an abstract accepted for the ADA 79th Scientific Sessions, T1D Exchange Quality Improvement Collaborative researchers found the time between visits grew with older patients in pediatric diabetes clinics.
At the American Diabetes Association Scientific Sessions, the T1D Exchange Quality Improvement Collaborative shared early findings from efforts to standardize data collection and improve care at pediatric diabetes clinics.